Litcius/Paper detail

Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome

Takashi Taga, Shiro Tanaka, Daisuke Hasegawa, Kiminori Terui, Tsutomu Toki, Shotaro Iwamoto, Hidefumi Hiramatsu, Takako Miyamura, Yoshiko Hashii, Hiroshi Moritake, Hideki Nakayama, Hiroyuki Takahashi, Akira Shimada, Tomohiko Taki, Etsuro Ito, Asahito Hama, Masafumi Ito, Katsuyoshi Koh, Daiichiro Hasegawa, Akiko Saito, Souichi Adachi, Daisuke Tomizawa

2021Leukemia19 citationsDOI

Topics & Concepts

MedicineInternal medicineHazard ratioMinimal residual diseaseGATA1OncologyMyeloid leukemiaPopulationInduction chemotherapyLeukemiaImmunologyChemotherapyConfidence intervalAnemiaEnvironmental healthErythropoiesisAcute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Myeloid Leukemia Treatments
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome | Litcius